| Shelby Wigginton, | |
|
2708 S Rife Medical Ln Ste 130, Rogers, AR 72758-1455 | |
| (479) 338-5555 | |
| (479) 338-5533 |
| Full Name | Shelby Wigginton |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 2708 S Rife Medical Ln Ste 130, Rogers, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083107452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 94-09485 (Kansas) | Secondary |
| 207Q00000X | Family Medicine | E-16541 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health Northwest Arkansas Communities | 0648177873 | 265 |
News Archive
We've all heard the adage, "If at first you don't succeed, try, try again," but new research from Carnegie Mellon University and the University of Pittsburgh finds that it isn't all about repetition. Rather, internal states like engagement can also have an impact on learning.
University of Louisville faculty researchers and clinicians with expertise in polypharmacy, caregiving and more will join with a Washington-based geriatric researcher at a free conference examining Alzheimer's disease.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced the successful implant of the first commercially-available remede system for patients with Central Sleep Apnea.
Open Monoclonal Technology, Inc. (OMT) today announced its new human antibody platform using the first genetically engineered rats expressing a human antibody repertoire. The company, which also created the first targeted knockout rats in 2009, is now cross-breeding the knockout animals with the rats expressing human antibodies to finalize its platform.
› Verified 1 days ago
| Entity Name | Mercy Health Northwest Arkansas Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265490916 PECOS PAC ID: 0648177873 Enrollment ID: O20031216000788 |
News Archive
We've all heard the adage, "If at first you don't succeed, try, try again," but new research from Carnegie Mellon University and the University of Pittsburgh finds that it isn't all about repetition. Rather, internal states like engagement can also have an impact on learning.
University of Louisville faculty researchers and clinicians with expertise in polypharmacy, caregiving and more will join with a Washington-based geriatric researcher at a free conference examining Alzheimer's disease.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced the successful implant of the first commercially-available remede system for patients with Central Sleep Apnea.
Open Monoclonal Technology, Inc. (OMT) today announced its new human antibody platform using the first genetically engineered rats expressing a human antibody repertoire. The company, which also created the first targeted knockout rats in 2009, is now cross-breeding the knockout animals with the rats expressing human antibodies to finalize its platform.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelby Wigginton, Po Box 776084, Chicago, IL 60677-6084 Ph: (314) 543-6979 | Shelby Wigginton, 2708 S Rife Medical Ln Ste 130, Rogers, AR 72758-1455 Ph: (479) 338-5555 |
News Archive
We've all heard the adage, "If at first you don't succeed, try, try again," but new research from Carnegie Mellon University and the University of Pittsburgh finds that it isn't all about repetition. Rather, internal states like engagement can also have an impact on learning.
University of Louisville faculty researchers and clinicians with expertise in polypharmacy, caregiving and more will join with a Washington-based geriatric researcher at a free conference examining Alzheimer's disease.
Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced the successful implant of the first commercially-available remede system for patients with Central Sleep Apnea.
Open Monoclonal Technology, Inc. (OMT) today announced its new human antibody platform using the first genetically engineered rats expressing a human antibody repertoire. The company, which also created the first targeted knockout rats in 2009, is now cross-breeding the knockout animals with the rats expressing human antibodies to finalize its platform.
› Verified 1 days ago
Anthony Meloy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4305 S Pleasant Crossing Blvd Ste 3, Rogers, AR 72758 Phone: 479-289-8376 | |
Dr. John Newland Redwine, DO, FAAFP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 24 Bracebridge Rd, Rogers, AR 72756 Phone: 479-871-1981 | |
Dr. Dustin Paul Pope, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5206 W Village Pkwy Ste 10, Rogers, AR 72758 Phone: 479-657-6600 Fax: 479-657-6632 | |
Dr. Andrew White, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2710 S Rife Medical Ln, Rogers, AR 72758 Phone: 479-338-8000 | |
Dr. Amanda Marie Ferguson Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2708 S Rife Medical Ln, Rogers, AR 72758 Phone: 479-338-5555 Fax: 479-338-5533 | |
Martin A Hannon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3730 S Pinnacle Hills Pkwy Ste 2, Rogers, AR 72758 Phone: 479-464-5599 Fax: 479-464-5598 |